Ethics Subcommittee, Advisory Committee to the Director, Centers for Disease Control and Prevention (CDC), 62996 [E8-25126]
Download as PDF
<![CDATA[
62996
Federal Register / Vol. 73, No. 205 / Wednesday, October 22, 2008 / Notices
announces the following meeting of the
aforementioned committee:
Time and Date: 8:30 a.m.–5 p.m.,
November 20, 2008.
Place: CDC, Global Communications
Center, Building 19, Rooms 245–246, 1600
Clifton Road, Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available.
Purpose: The committee shall advise the
Secretary, HHS, and the Director, CDC,
concerning strategies and goals for the
programs and research within the national
centers; shall conduct peer-review of
scientific programs; and monitor the overall
strategic direction and focus of the national
centers.
The board, after conducting its periodic
reviews, shall submit a written description of
the results of the review and its
recommendations to the Director, CDC. The
board shall perform second-level peer review
of applications for grants-in-aid for research
and research training activities, cooperative
agreements, and research contract proposals
relating to the broad areas within the national
centers.
Matters to be Discussed: The agenda will
include detailed discussions on the following
issues: BioSense Strategic Planning, Open
Source Models, and Organizational Issues for
NCPHI.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information: Scott
J.N. McNabb, Ph.D., M.S., Designated Federal
Officer, NCPHI, CDC, 1600 Clifton Road, NE.,
Mailstop E78, Atlanta, Georgia, 30333,
Telephone: (404) 409–3898.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: October 15, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–25131 Filed 10–21–08; 8:45 am]
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, Maryland 20852, Telephone: (301)
822–9200, Fax: (301) 822–9201.
Status: Open to the public, limited only by
the space available. The meeting room will
accommodate approximately 100 people.
Purpose: This Committee is charged with
advising the Director, CDC and the
Administrator, HRSA, regarding activities
related to prevention and control of HIV/
AIDS and other STDs, the support of health
care services to persons living with HIV/
AIDS, and education of health professionals
and the public about HIV/AIDS and other
STDs.
Matters to be Discussed: Agenda items
include issues pertaining to (1) HRSA Bureau
of Primary Health Care focusing on
Community Health Centers; (2) CDC’s revised
HIV incidence and prevalence estimates; (3)
Key expert clinical data—Domestic and the
President’s Emergency Plan for AIDS Relief;
and (4) Presentation on interface between
mental health services and HIV/STD issues,
including risk issues and comprehensive and
synergistic care. Agenda items are subject to
change as priorities dictate.
Contact Person for More Information: Traci
Sears, Committee Management Specialist,
CDC, Strategic Business Unit, 1600 Clifton
Road, NE., Mailstop E–77, Atlanta, Georgia
30333, Telephone: (404) 498–2732, Fax: (404)
498–2708.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
both the CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: October 15, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–25129 Filed 10–21–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 50 people. To
accommodate public participation in the
meeting, a conference telephone line will be
available. The public is welcome to
participate during the public comment
periods by calling (866) 919–3560 and
entering code 4168828. The public comment
periods are tentatively scheduled for 4:30
p.m.–4:45 p.m. on November 13 and from
2:30 p.m.–2:45 p.m. on November 14, 2008.
Purpose: The Ethics Subcommittee will
provide guidance to the ACD, CDC, regarding
a broad range of public health ethics
questions and issues arising from programs,
scientists and practitioners.
Matters To Be Discussed: Agenda items
will include the following topics: CDC’s
Healthiest Nation Initiative, priorities of the
Advisory Committee to the Director, ethical
guidance for ventilator distribution, ethical
guidance for use of traveler restrictions,
ethical guidance for public health emergency
preparedness and response, survey of CDC
staff about principles of ethical public health
practice, development of a web-based course
on public health ethics, and the CDC–
Tuskegee University Public Health Ethics
Fellowship.
For Further Information Contact: For
security reasons, members of the public
interested in attending the meeting should
contact Drue Barrett, PhD, Designated
Federal Officer, Ethics Subcommittee, CDC,
1600 Clifton Road, NE., M/S D–50, Atlanta,
Georgia 30333. Telephone (404) 639–4690. Email: dbarrett@cdc.gov. The deadline for
notification of attendance is November 7,
2008.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: October 15, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–25126 Filed 10–21–08; 8:45 am]
Centers for Disease Control and
Prevention
Ethics Subcommittee, Advisory
Committee to the Director, Centers for
Disease Control and Prevention (CDC)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention (CDC)
sroberts on PROD1PC70 with NOTICES
CDC/Health Resources and Services
Administration (HRSA) Advisory
Committee on HIV and STD Prevention
and Treatment
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the CDC announces
the following meeting of the
aforementioned committee:
Times and Dates: 8 a.m.–5 p.m., November
17, 2008. 8 a.m.–3 p.m., November 18, 2008.
VerDate Aug<31>2005
17:50 Oct 21, 2008
Jkt 217001
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention announces the
aforementioned subcommittee meeting.
Name: Ethics Subcommittee, Advisory
Committee to the Director (ACD), CDC.
Times and Dates: 1 p.m.–5 p.m., November
13, 2008. 8 a.m.–3 p.m., November 14, 2008.
Place: Centers for Disease Control and
Prevention, Thomas R. Harkin Global
Communication Center, 1600 Clifton Road,
Atlanta, Georgia 30333.
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
Centers for Disease Control and
Prevention
Interagency Committee on Smoking
and Health (ICSH)
In accordance with section 10(a) (2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following Meeting of the
aforementioned committee:
Time and Date: 9 a.m.–4:30 p.m.,
December 8, 2008.
E:\FR\FM\22OCN1.SGM
22OCN1
]]>Agencies
[Federal Register Volume 73, Number 205 (Wednesday, October 22, 2008)]
[Notices]
[Page 62996]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-25126]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Ethics Subcommittee, Advisory Committee to the Director, Centers
for Disease Control and Prevention (CDC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention announces the aforementioned subcommittee meeting.
Name: Ethics Subcommittee, Advisory Committee to the Director
(ACD), CDC.
Times and Dates: 1 p.m.-5 p.m., November 13, 2008. 8 a.m.-3
p.m., November 14, 2008.
Place: Centers for Disease Control and Prevention, Thomas R.
Harkin Global Communication Center, 1600 Clifton Road, Atlanta,
Georgia 30333.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 50 people. To
accommodate public participation in the meeting, a conference
telephone line will be available. The public is welcome to
participate during the public comment periods by calling (866) 919-
3560 and entering code 4168828. The public comment periods are
tentatively scheduled for 4:30 p.m.-4:45 p.m. on November 13 and
from 2:30 p.m.-2:45 p.m. on November 14, 2008.
Purpose: The Ethics Subcommittee will provide guidance to the
ACD, CDC, regarding a broad range of public health ethics questions
and issues arising from programs, scientists and practitioners.
Matters To Be Discussed: Agenda items will include the following
topics: CDC's Healthiest Nation Initiative, priorities of the
Advisory Committee to the Director, ethical guidance for ventilator
distribution, ethical guidance for use of traveler restrictions,
ethical guidance for public health emergency preparedness and
response, survey of CDC staff about principles of ethical public
health practice, development of a web-based course on public health
ethics, and the CDC-Tuskegee University Public Health Ethics
Fellowship.
For Further Information Contact: For security reasons, members
of the public interested in attending the meeting should contact
Drue Barrett, PhD, Designated Federal Officer, Ethics Subcommittee,
CDC, 1600 Clifton Road, NE., M/S D-50, Atlanta, Georgia 30333.
Telephone (404) 639-4690. E-mail: dbarrett@cdc.gov. The deadline for
notification of attendance is November 7, 2008.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: October 15, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E8-25126 Filed 10-21-08; 8:45 am]
BILLING CODE 4163-18-P
